Ozan Pamir insider trades: Niagen Bioscience (NAGE) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Ozan reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 14, 2025 | NAGE | ↑ Buy | 4,465 | $6.81 | $30K | Direct | Nov 17, 2025 (3d) |
| Nov 14, 2025 | NAGE | ↑ Buy | 2,220 | $6.85 | $15K | The reported securities are held by the | Nov 17, 2025 (3d) |
| Nov 22, 2024 | CDXC | ↑ Buy | 2,907 | $7.36 | $21K | Direct | Nov 25, 2024 (3d) |
| May 18, 2023 | ATNF | ↑ Buy | 5,162 | $1.01 | $5K | Direct | May 19, 2023 (1d) |
| Dec 10, 2021 | ATNF | ↑ Buy | 3,800 | $3.87 | $15K | Direct | Dec 13, 2021 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Ozan Pamir's insider trades
Ozan Pamir is Chief Financial Officer at Niagen Bioscience (NAGE). Since Dec 10, 2021, Ozan has reported 5 open-market purchases worth $87K and no sales on SEC Form 4. In the last 12 months: 2 buys ($46K).
Their filings also include grants and awards (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NAGE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.